Nizzardo et al. (2016) treated ALS MN-iPSCs with ASOs designed to reduce the synthesis of human SOD1 and observed an increased survival and reduced expression of apoptotic markers in treated cells. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.